Symbol | Exchange | Currency |
|---|
Investing.com - Madrigal Pharma (NASDAQ: MDGL) reported fourth quarter EPS of $-4.98, $0.36 worse than the analyst estimate of $-4.62. Revenue for the quarter came in at $0.00...
The promising but challenging indication of nonalcoholic steatohepatitis (NASH) hit headlines following two major developments.Firstly, the frontrunner in the NASH space, Intercept...
Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) gained 7.5% after the company posted mixed results for the fourth quarter of 2018 wherein even though earnings missed...
Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) rose about 6.1% after the company announced positive top-line results from its pivotal phase III REGENERATE study of...
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.
| Average | 313.17 (+30.05% Upside) |
| High | 390.00 |
| Low | 194.00 |
| Price | 240.80 |
| No. of Analysts | 12 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Sell | Neutral | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Neutral | Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 189.19 | 192.35 | 185.43 | -2.62 | -1.37% | 98.10M | NASDAQ | |||
| 157.65 | 158.49 | 155.98 | -0.63 | -0.40% | 45.55M | NASDAQ | |||
| 61.42 | 61.74 | 61.27 | +0.07 | +0.11% | 9.67M | NYSE | |||
| 200.68 | 201.03 | 197.90 | -2.16 | -1.06% | 19.09M | NASDAQ | |||
| 101.03 | 102.45 | 99.74 | -1.43 | -1.40% | 31.92M | NASDAQ | |||
| 275.23 | 276.14 | 272.05 | -1.15 | -0.42% | 21.83M | NASDAQ | |||
| 39.99 | 40.30 | 39.86 | -0.23 | -0.57% | 13.34M | NYSE | |||
| 94.56 | 96.94 | 92.87 | -2.05 | -2.12% | 58.48M | NASDAQ | |||
| 97.24 | 98.44 | 96.29 | -0.80 | -0.82% | 38.55M | NASDAQ | |||
| 158.98 | 159.07 | 155.80 | +2.40 | +1.53% | 1.82M | NASDAQ | |||
| 264.10 | 265.13 | 258.50 | -1.21 | -0.46% | 35.45M | NASDAQ | |||
| 8.00 | 8.12 | 7.97 | -0.04 | -0.50% | 14.82M | NYSE | |||
| 101.36 | 103.00 | 100.28 | -1.70 | -1.65% | 24.71M | NASDAQ | |||
| 44.31 | 45.39 | 44.00 | -0.76 | -1.69% | 8.81M | NYSE | |||
| 10.27 | 10.27 | 10.24 | 0.00 | 0.00% | 1.20K | NYSE |